I agree Soul_surfer, with an option to share price ratio of 1:2.4c, there is little to gain from the added leverage in the options, imo! The share price not only needs to rise high enough to move the options, it needs to both hold the gains and offer continuing upside.
At 2.4c, the shares are priced like options.
- Forums
- ASX - By Stock
- PEN
- some serious buy @2.3
some serious buy @2.3, page-50
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PEN (ASX) to my watchlist
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $366.3M |
Open | High | Low | Value | Volume |
11.5¢ | 11.8¢ | 11.0¢ | $895.0K | 7.936M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 864316 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 1596253 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 844316 | 0.110 |
30 | 5458339 | 0.105 |
87 | 11711608 | 0.100 |
7 | 578212 | 0.099 |
11 | 484076 | 0.098 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 1385283 | 14 |
0.120 | 8218945 | 62 |
0.125 | 3433417 | 27 |
0.130 | 1763601 | 24 |
0.135 | 2295362 | 14 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PEN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online